• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Appl Thromb Hemost . Diagnostic Accuracy of D-Dimers for Predicting Pulmonary Embolism in COVID-19-Patients

tetano

Editor, Senior Moderator
Clin Appl Thromb Hemost


. Jan-Dec 2021;27:10760296211057901.
doi: 10.1177/10760296211057901.
Diagnostic Accuracy of D-Dimers for Predicting Pulmonary Embolism in COVID-19-Patients


Falmata Laouan Brem[SUP] 1 [/SUP], Boudouh Asmae[SUP] 2 [/SUP], Yassine Amane[SUP] 3 [/SUP], Mohammed-Amine Bouazzaoui[SUP] 4 [/SUP], Miri Chaymae[SUP] 1 [/SUP], Hammam Rasras[SUP] 1 [/SUP], Siham Nasri[SUP] 3 [/SUP], Naima Abda[SUP] 4 [/SUP], Imane Skiker[SUP] 3 [/SUP], Hatim Kouismi[SUP] 2 [/SUP], Bazid Zakaria[SUP] 1 4 [/SUP], Nabila Ismaili[SUP] 1 4 [/SUP], Noha El Ouafi[SUP] 1 4 [/SUP]



Affiliations

Abstract

Importance: Proinflammatory and hypercoagulable states with marked elevation seen in D-Dimer levels have been accurately described in patients infected by the SARS- Cov2 even without pulmonary embolism (PE).
Objectives: To compare D-dimers values in patients infected by the novel Coronavirus 2019 (COVID-19) with and without PE and to establish an optimal D-dimer cut-off to predict the occurrence of PE, which guides pulmonary computed tomography angiography (CTPA) indication.
Methods: We retrospectively enrolled all COVID-19-patients admitted between October first and November 22th, 2020, at the University Hospital Center of Mohammed VI, Oujda (Morocco), suspected to have PE and underwent a CTPA. Demographic characteristics and blood test results were compared between PE-positive and PE-negative. The receiver operating characteristics (ROC) curve was constructed to establish an optimal D-Dimer cut-off to predict the occurrence of PE.
Results: The study population consisted of 84 confirmed COVID-19-patients. The mean age was 64.93 years (SD 14.19). PE was diagnosed on CTPA in 31 (36.9%) patients. Clinical symptoms and in-hospital outcomes were similar in both groups except that more men had PE (p = .025). The median value of D-dimers in the group of patients with PE was significantly higher (14 680[IQR 33620-3450]ng/mL compared to the group of patients without PE 2980[IQR 6870-1600]ng/mL [P < .001]. A D-dimer at 2600 ng/mL was the optimal cut-off for predicting PE with a sensitivity of 90.3%, and AUC was .773[CI 95%, .667 -.876).
Conclusion: A D-dimer cut-off value of 2600 ng/mL is a significant predictor of PE in COVID-19-patients with a sensitivity of 90.3%.

Keywords: COVID-19; coagulopathy; d-dimers; pulmonary embolism; threshold.
 
Back
Top Bottom